NX210c, GLUCOSE 5 % B.BRAUN, solution pour perfusion
Phase 2 small_molecule active
Quick answer
NX210c, GLUCOSE 5 % B.BRAUN, solution pour perfusion for Amyotrophic Lateral Sclerosis (ALS) is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Amyotrophic Lateral Sclerosis (ALS)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active